Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates

<p>Abstract</p> <p>Background</p> <p>An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced.</p> <p>Results</p> <p>A known...

Full description

Bibliographic Details
Main Authors: Shainberg Asher, Lloyd John, Gao Zhan-Guo, Klutz Athena M, Jacobson Kenneth A
Format: Article
Language:English
Published: BMC 2008-10-01
Series:Journal of Nanobiotechnology
Online Access:http://www.jnanobiotechnology.com/content/6/1/12
_version_ 1798006466270986240
author Shainberg Asher
Lloyd John
Gao Zhan-Guo
Klutz Athena M
Jacobson Kenneth A
author_facet Shainberg Asher
Lloyd John
Gao Zhan-Guo
Klutz Athena M
Jacobson Kenneth A
author_sort Shainberg Asher
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced.</p> <p>Results</p> <p>A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers for delivery of the intact covalent conjugate to on the cell surface. Depending on the linking moiety, multivalent conjugates of the <it>N</it><sup>6</sup>-chain elongated functionalized congener ADAC (<it>N</it><sup>6</sup>-[4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]anilino]carbonyl]methyl]phenyl]-adenosine) achieved unanticipated high selectivity in binding to the cytoprotective human A<sub>3 </sub>AR, a class A GPCR. The key to this selectivity of > 100-fold in both radioreceptor binding (K<sub>i app </sub>= 2.4 nM) and functional assays (EC<sub>50 </sub>= 1.6 nM in inhibition of adenylate cyclase) was maintaining a free amino group (secondary) in an amide-linked chain. Attachment of neutral amide-linked chains or thiourea-containing chains preserved the moderate affinity and efficacy at the A<sub>1 </sub>AR subtype, but there was no selectivity for the A<sub>3 </sub>AR. Since residual amino groups on dendrimers are associated with cytotoxicity, the unreacted terminal positions of this A<sub>3 </sub>AR-selective G2.5 dendrimer were present as carboxylate groups, which had the further benefit of increasing water-solubility. The A<sub>3 </sub>AR selective G2.5 dendrimer was also visualized binding the membrane of cells expressing the A<sub>3 </sub>receptor but did not bind cells that did not express the receptor.</p> <p>Conclusion</p> <p>This is the first example showing that it is feasible to modulate and even enhance the pharmacological profile of a ligand of a GPCR based on conjugation to a nanocarrier and the precise structure of the linking group, which was designed to interact with distal extracellular regions of the 7 transmembrane-spanning receptor. This ligand tool can now be used in pharmacological models of tissue rescue from ischemia and to probe the existence of A<sub>3 </sub>AR dimers.</p>
first_indexed 2024-04-11T12:55:28Z
format Article
id doaj.art-a0f3a722916e416faef867a1a66233c0
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-11T12:55:28Z
publishDate 2008-10-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-a0f3a722916e416faef867a1a66233c02022-12-22T04:23:05ZengBMCJournal of Nanobiotechnology1477-31552008-10-01611210.1186/1477-3155-6-12Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugatesShainberg AsherLloyd JohnGao Zhan-GuoKlutz Athena MJacobson Kenneth A<p>Abstract</p> <p>Background</p> <p>An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced.</p> <p>Results</p> <p>A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers for delivery of the intact covalent conjugate to on the cell surface. Depending on the linking moiety, multivalent conjugates of the <it>N</it><sup>6</sup>-chain elongated functionalized congener ADAC (<it>N</it><sup>6</sup>-[4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]anilino]carbonyl]methyl]phenyl]-adenosine) achieved unanticipated high selectivity in binding to the cytoprotective human A<sub>3 </sub>AR, a class A GPCR. The key to this selectivity of > 100-fold in both radioreceptor binding (K<sub>i app </sub>= 2.4 nM) and functional assays (EC<sub>50 </sub>= 1.6 nM in inhibition of adenylate cyclase) was maintaining a free amino group (secondary) in an amide-linked chain. Attachment of neutral amide-linked chains or thiourea-containing chains preserved the moderate affinity and efficacy at the A<sub>1 </sub>AR subtype, but there was no selectivity for the A<sub>3 </sub>AR. Since residual amino groups on dendrimers are associated with cytotoxicity, the unreacted terminal positions of this A<sub>3 </sub>AR-selective G2.5 dendrimer were present as carboxylate groups, which had the further benefit of increasing water-solubility. The A<sub>3 </sub>AR selective G2.5 dendrimer was also visualized binding the membrane of cells expressing the A<sub>3 </sub>receptor but did not bind cells that did not express the receptor.</p> <p>Conclusion</p> <p>This is the first example showing that it is feasible to modulate and even enhance the pharmacological profile of a ligand of a GPCR based on conjugation to a nanocarrier and the precise structure of the linking group, which was designed to interact with distal extracellular regions of the 7 transmembrane-spanning receptor. This ligand tool can now be used in pharmacological models of tissue rescue from ischemia and to probe the existence of A<sub>3 </sub>AR dimers.</p>http://www.jnanobiotechnology.com/content/6/1/12
spellingShingle Shainberg Asher
Lloyd John
Gao Zhan-Guo
Klutz Athena M
Jacobson Kenneth A
Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
Journal of Nanobiotechnology
title Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_full Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_fullStr Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_full_unstemmed Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_short Enhanced A<sub>3 </sub>adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_sort enhanced a sub 3 sub adenosine receptor selectivity of multivalent nucleoside dendrimer conjugates
url http://www.jnanobiotechnology.com/content/6/1/12
work_keys_str_mv AT shainbergasher enhancedasub3subadenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT lloydjohn enhancedasub3subadenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT gaozhanguo enhancedasub3subadenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT klutzathenam enhancedasub3subadenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT jacobsonkennetha enhancedasub3subadenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates